Print

Alltracel Pharmaceuticals Plc Announces Nanopeutics Agreement  
11/12/2007 10:10:04 AM

Alltracel Pharmaceuticals Plc., ("Alltracel" or "the Company"), (AIM:AP.L), the healthcare innovation group focused on oral care, wound care, cardiovascular health and dermal health markets, today announces that its Nanopeutics subsidiary has signed a collaborative technology development agreement with ConvaTec, a world-leading manufacturer of ostomy and wound care products with a 25-year heritage of caring for patients.
//-->